Overcoming Liquid Biopsy Barriers: Nucleic Acid Biosensors Integrating DNA Nanotechnology and CRISPR-Cas System for Cancer Precision Theranostics.
- DOI
- 10.1021/acssensors.6c01673
- Published
- 2026 Aug 28
- Container
- ACS sensors
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acssensors.6c01673,
title = {Overcoming Liquid Biopsy Barriers: Nucleic Acid Biosensors Integrating DNA Nanotechnology and CRISPR-Cas System for Cancer Precision Theranostics.},
author = {Lv Y and Kulsoom and Jia L and Wang Z and Wang F},
year = {2026},
journal = {ACS sensors},
doi = {10.1021/acssensors.6c01673},
url = {https://doi.org/10.1021/acssensors.6c01673}
}RIS
TY - JOUR TI - Overcoming Liquid Biopsy Barriers: Nucleic Acid Biosensors Integrating DNA Nanotechnology and CRISPR-Cas System for Cancer Precision Theranostics. AU - Lv Y AU - Kulsoom AU - Jia L AU - Wang Z AU - Wang F PY - 2026 JO - ACS sensors DO - 10.1021/acssensors.6c01673 UR - https://doi.org/10.1021/acssensors.6c01673 ER -
APA
Y, L., Kulsoom, L, J., Z, W., & F, W. (2026). Overcoming Liquid Biopsy Barriers: Nucleic Acid Biosensors Integrating DNA Nanotechnology and CRISPR-Cas System for Cancer Precision Theranostics.. ACS sensors. https://doi.org/10.1021/acssensors.6c01673
Source records
- pubmed · retrieved 2026-09-26T09:24:57.354Z